Serum Cytotoxic Factor and its' Inhibitorin Rheumatoid Arthritis.

血清细胞毒性因子及其抑制剂类风湿性关节炎。

基本信息

  • 批准号:
    04807106
  • 负责人:
  • 金额:
    $ 1.02万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1993
  • 项目状态:
    已结题

项目摘要

The peripheral blood serum of patients with severe active rheumatoid arthritis (RA) was found to have a cytotoxic effect on autologous mononuclear cells. The cytotoxic factor was partially purified and shown to have a molecular weight of about 900 kd, using gel filtration. The factor differed from cytokines such as tumor necrosis factor-alpha (TNF-alpha) and also differed from complement components. It also differed from hydrolytic enzyme such as protease, collagenase, and phospholipase A_2. It destroyed normal peripheral blood mononuclear cells in vitro at the same concentration as it found in vivo, and also nonspecifically destroyed such human cell lines as CCRF-CEM, Raji, U-937, and HL-60. Each RA patient with this serum cytotoxic factor had severe systemic tissue disease as well as rapid and severe destruction of most joints. Thus, we have identified a cytotoxic factor in RA serum which causes systemic tissue damage. And we also partially pirified the inhibitor against the cytotoxic factor, using gel filtration.
发现严重活动性类风湿关节炎(RA)患者外周血血清对自体单核细胞具有细胞毒性作用。经凝胶过滤,细胞毒性因子部分纯化,分子量约为900 kd。该因子不同于细胞因子,如肿瘤坏死因子- α (tnf - α),也不同于补体成分。它也不同于蛋白酶、胶原酶、磷脂酶A_2等水解酶。它在体外以与体内相同的浓度破坏正常外周血单个核细胞,并非特异性地破坏CCRF-CEM、Raji、U-937和HL-60等人细胞系。每个患有这种血清细胞毒因子的RA患者都有严重的全身性组织疾病,并且大多数关节都有快速而严重的破坏。因此,我们已经在类风湿性关节炎血清中确定了一种细胞毒性因子,它会导致全身组织损伤。我们也用凝胶过滤,部分提纯了抑制细胞毒性因子的抑制剂。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ochi,T: "Therapeutic Effect of Intradermal Injections with Difucosyl Lactosamine(Dimeric Lex)on Patients with Rheumatoide Arthritis." The Journal of Rheumatology. 20. 2038-2045 (1993)
Ochi,T:“皮内注射二岩藻糖基乳糖胺(二聚 Lex)对类风湿性关节炎患者的治疗效果。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hayashida K, Ochi T, Fujimoto M, Owaki H, Shimaoka Y, Ono K, Matsumoto K.: "Bone marrow changes in adjuvant-inducedand collagen-inducedarthritis." Arthritis and Rheumatism. 35. 241-245 (1992)
Hayashida K、Ochi T、Fujimoto M、Owaki H、Shimaoka Y、Ono K、Matsumoto K.:“佐剂诱导和胶原诱导的关节炎中的骨髓变化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
島岡康則: "慢性関節リウマチ患者に認めた新しい細胞傷害性因子.全身性組織傷害と非特異的細胞傷害性因子" 日整形会誌. 66. 1292 (1992)
Yasunori Shimaoka:“在类风湿性关节炎患者中发现的一种新的细胞毒性因子。全身组织损伤和非特异性细胞毒性因子”日本骨科学会杂志 66. 1292 (1992)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujimoto,M: "Fluctuation of interleukin-1 and-6 activity in bone marrow serum in collagen-induced arthritis in rats." Biomedical Research. 13. 243-251 (1992)
Fujimoto,M:“胶原诱导的大鼠关节炎中骨髓血清中白介素 1 和 6 活性的波动。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hayashida,K: "Bone marrow changes in adjuvant-induced and collagen-induced arthritis." Arthritis and Rheumatism. 35. 241-245 (1992)
Hayashida,K:“佐剂诱导和胶原诱导的关节炎中的骨髓变化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OCHI Takahiro其他文献

OCHI Takahiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OCHI Takahiro', 18)}}的其他基金

Involvement of bone marrow interstitial fibroblastic cells which support the differentiation of CD(+) peripheral-blood monocytes into TRAP positive cells. In bone and cartilage destruction in rheumatoid arthritis.
骨髓间质成纤维细胞的参与支持 CD(+) 外周血单核细胞分化为 TRAP 阳性细胞。
  • 批准号:
    13470311
  • 财政年份:
    2001
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of pathological role of RA Nurse-like cells in Joint destruction of RA
RA Nurse样细胞在RA关节破坏中的病理作用分析
  • 批准号:
    11470309
  • 财政年份:
    1999
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Molecular analysis of interaction between hematopoietic cells and nurse cells established from patients with rheumatoid arthritis
类风湿性关节炎患者造血细胞和护理细胞之间相互作用的分子分析
  • 批准号:
    09470317
  • 财政年份:
    1997
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of in vivo direct gene transfer system into joint using HVJ-liposome
HVJ-脂质体体内直接基因转移系统的建立
  • 批准号:
    07557098
  • 财政年份:
    1995
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Abnormal Myeloid Lineage Cells Expressing the Difucosyl or Trifucosyl Type 2 Chain in Bone Marrow Cells of Patinets with Severe Rheumatoid Arthritis.
患有严重类风湿性关节炎的患者骨髓细胞中表达二岩藻糖基或三岩藻糖基 2 型链的异常骨髓谱系细胞。
  • 批准号:
    06454429
  • 财政年份:
    1994
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
癌細胞特異糖鎖抗原による慢性関節リウマチ患者に対する感作療法
使用癌细胞特异性碳水化合物抗原对类风湿性关节炎患者进行敏化治疗
  • 批准号:
    04557066
  • 财政年份:
    1992
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Development of Intradermal Sensitization Therapy to Ra Patients Using Oncofetal Carbohydrate Membrane Structure
利用癌胎碳水化合物膜结构开发 Ra 患者皮内致敏疗法
  • 批准号:
    01870065
  • 财政年份:
    1992
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
Myeloid cell cascade bearing onco-fetal membrane structure found in the involved epiphyseal bone marrow in patients with severe active rheumatoid arthritis
在严重活动性类风湿关节炎患者受累骨骺骨髓中发现具有癌胎膜结构的骨髓细胞级联
  • 批准号:
    02454345
  • 财政年份:
    1990
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Investigation of Mergo? mechanism of action by quantitative serum protein profiling.
调查梅尔戈?
  • 批准号:
    10074412
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Collaborative R&D
Development of novel therapeutic approach using serum exosomes to conquer bone metastases from lung cancer
使用血清外泌体开发新的治疗方法来克服肺癌骨转移
  • 批准号:
    23K06704
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creating an optimized and scalable production platform in suspension adapted serum-free HEK293 cells for rAAV gene delivery using a Design-of-Experime
使用实验设计在悬浮适应的无血清 HEK293 细胞中创建优化且可扩展的生产平台,用于 rAAV 基因递送
  • 批准号:
    2776049
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Studentship
Pathophysiology and prevention of degeneration of heterograft biomaterials due to advanced glycation end products and serum protein infiltration
由于晚期糖基化终产物和血清蛋白浸润导致异种移植生物材料变性的病理生理学和预防
  • 批准号:
    10679910
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Role of serum advanced glycation end-products in altering tendon properties with diabetes
血清晚期糖基化终末产物在改变糖尿病肌腱特性中的作用
  • 批准号:
    10737036
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
  • 批准号:
    10794761
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Placental Serum Amyloid A as a Therapeutic Target to Prevent Preterm Birth and Prematurity Related Morbidity
胎盘血清淀粉样蛋白 A 作为预防早产和早产相关发病的治疗靶点
  • 批准号:
    10742411
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Prevalence and Genotype Distribution of HDV using in-house developed ELISA in both serum and dried blood spots samples of pregnant women and their newborns in Siem Reap, Cambodia
使用内部开发的 ELISA 检测柬埔寨暹粒孕妇及其新生儿的血清和干血斑样本中丁型肝炎病毒的流行率和基因型分布
  • 批准号:
    23K16303
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identification of microbiota-dependent serum metabolites associated with immune activation using PD-1 deficient mice model
使用 PD-1 缺陷小鼠模型鉴定与免疫激活相关的微生物依赖的血清代谢物
  • 批准号:
    23K06603
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Prospective study on the diagnostic accuracy of early gastric cancer by serum methylated RUNX3
血清甲基化RUNX3诊断早期胃癌准确性的前瞻性研究
  • 批准号:
    23K06910
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了